<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Polyclonal anti-S react with Met<sup>28</sup> or red blood cell (RBC) bound gly cophorin B (GPB) but may also require adjacent amino acids. Treatment of RBCs with certain enzymes and sodium hypochlorite based bleach (NaClO) affect the interaction of GPB with anti-S. Some, but not all, anti-S react with hybrid glycopborin molecules associated with the TSEN antigen. The purpose of this study was to characterize monoclonal anti-S and to compare their reactivity to polyclonal anti-S in order to determine their potential as blood group reagents and research tools. Furthermore, through inhibition experiments, we attempted to define the epitope recognized by the antibodies. Three monoclonal (MS-93: MS-94; MS-95) and two polyclonal (Al958; X1960) anti-S anti a monoclonal anti-GPB (Mab 148) were tested by standard hemagglutination with RBCs of known common and rare phenotype, with S+ RBCs treated with enzymes, with different concentrations of NaClO, and after incubation with synthetic peptides. The anti-S gave different patterns of reactivity. Reactivity with sialidase-treated RBCs showed that MS-93, MS-95. Mab 148. and X1960 recognize sialic acid independent epitopes, whereas MS-94 and A1958 require sialic acid for optimal reactivity. MS-95 and X1960 were strongly reactive with TSEN+ RBCs and only Mab 148 agglutinated S- Dantu+ and S- St(a+) RBCs MS-94 and Mab 148 agglutinated S+ RBCs treated with NaClO. MS-93 was inhibited only by the 14-mer S-specific synthetic peptide whereas MS-95 was inhibited by all three synthetic peptides containing S-relevant residues. This study clearly demonstrates that different anti-S have different characteristics that should be analyzed before selecting monoclonal antibodies for the basis of reagents for use in the clinical laboratory. These anti-S, because of their varied characteristics, will be useful research tools. <italic>Immunohematology</italic> 1999; 15:163-166.</p></abstract>

Polyclonal anti-S react with Met28 or red blood cell (RBC) bound gly cophorin B (GPB) but may also require adjacent amino acids. Treatment of RBCs with certain enzymes and sodium hypochlorite based bleach (NaClO) affect the interaction of GPB with anti-S. Some, but not all, anti-S react with hybrid glycopborin molecules associated with the TSEN antigen. The purpose of this study was to characterize monoclonal anti-S and to compare their reactivity to polyclonal anti-S in order to determine their potential as blood group reagents and research tools. Furthermore, through inhibition experiments, we attempted to define the epitope recognized by the antibodies. Three monoclonal (MS-93: MS-94; MS-95) and two polyclonal (Al958; X1960) anti-S anti a monoclonal anti-GPB (Mab 148) were tested by standard hemagglutination with RBCs of known common and rare phenotype, with S+ RBCs treated with enzymes, with different concentrations of NaClO, and after incubation with synthetic peptides. The anti-S gave different patterns of reactivity. Reactivity with sialidase-treated RBCs showed that MS-93, MS-95. Mab 148. and X1960 recognize sialic acid independent epitopes, whereas MS-94 and A1958 require sialic acid for optimal reactivity. MS-95 and X1960 were strongly reactive with TSEN+ RBCs and only Mab 148 agglutinated S- Dantu+ and S- St(a+) RBCs MS-94 and Mab 148 agglutinated S+ RBCs treated with NaClO. MS-93 was inhibited only by the 14-mer S-specific synthetic peptide whereas MS-95 was inhibited by all three synthetic peptides containing S-relevant residues. This study clearly demonstrates that different anti-S have different characteristics that should be analyzed before selecting monoclonal antibodies for the basis of reagents for use in the clinical laboratory. These anti-S, because of their varied characteristics, will be useful research tools. Immunohematology 1999; 15:163-166.

Evaluation and comparison of three human monoclonal anti-S, two human polyclonal anti-S, and one murine anti-GPB

Immunohematology

Polyclonal anti-S react with Met28 or red blood cell (RBC) bound gly cophorin B (GPB) but may also require adjacent amino acids. Treatment of RBCs with certain...

Evaluation and comparison of three human monoclonal anti-S, two human polyclonal anti-S, and one murine anti-GPB

Pubblicato online: 26 ott 2020

Pagine: 163 - 166

DOI: https://doi.org/10.21307/immunohematology-2019-639

Parole chiave
monoclonal, anti-S, glycopborin-B antibodies, MNS antibodies

© 1999 G.R Halverson et al., published by Sciendo

Evaluation and comparison of three human monoclonal anti-S, two human polyclonal anti-S, and one murine anti-GPB

Pubblicato online: 26 ott 2020

Pagine: 163 - 166

DOI: https://doi.org/10.21307/immunohematology-2019-639

Parole chiavemonoclonal, anti-S, glycopborin-B antibodies, MNS antibodies

© 1999 G.R Halverson et al., published by Sciendo

Parole chiave
monoclonal, anti-S, glycopborin-B antibodies, MNS antibodies